Back
908 Devices Vs. Perspective Therapeutics Industry Stock Comparison
Buy
62
MASS
908 Devices
Last Price:
5.76
Seasonality Move:
-6.68%
Buy
70
CATX
Perspective Therapeutics
Last Price:
1.79
Seasonality Move:
3.58%
Buy
62
908 Devices (MASS)
is a Buy
Is 908 Devices a Buy, Sell or Hold?
- The current 908 Devices [MASS] share price is $5.77. The Score for MASS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MASS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.80. The Score for CATX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MASS Stock Price Chart
What is 908 Devices's stock price today?
-
The 908 Devices share price today is $5.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MASS is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight buying pressure.
MASS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 43.64 | Sell |
| Chaikin Money Flow: | -186862 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.48 - 6.24) | Sell |
| Bollinger Bands (100): | (5.97 - 8.43) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 66.46 | Buy |
| Chaikin Money Flow: | 2851917 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.48 - 1.74) | Buy |
| Bollinger Bands (100): | (0.58 - 1.46) | Buy |
MASS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.69 | Buy |
| 20-day SMA: | 5.68 | Buy |
| 50-day SMA: | 6.37 | Sell |
| 200-day SMA: | 6.87 | Sell |
| 8-day EMA: | 5.7 | Buy |
| 20-day EMA: | 5.82 | Sell |
| 50-day EMA: | 6.27 | Sell |
| 200-day EMA: | 7.27 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Buy |
| 20-day SMA: | 1.64 | Buy |
| 50-day SMA: | 1.39 | Buy |
| 200-day SMA: | 0.67 | Buy |
| 8-day EMA: | 1.76 | Buy |
| 20-day EMA: | 1.65 | Buy |
| 50-day EMA: | 1.41 | Buy |
| 200-day EMA: | 0.86 | Buy |
908 Devices Earnings Growth & MASS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.01 per share, and an increase next year of $0.15 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
908 Devices Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||